Mast cells promote malaria infection?

Theoharis C Theoharides1

  • 1Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, Massachusetts; Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts; Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts.

Clinical Therapeutics
|April 5, 2015
PubMed
Abstract

Insights

Malaria parasites may worsen disease by activating mast cells (MCs), leading to pathogenic CD8(+) T cells. Inhibiting MCs could be a new malaria treatment.

Area of Science:

  • Immunology
  • Parasitology
  • Tropical Medicine

Background:

  • Malaria, caused by Plasmodium falciparum, is a deadly parasitic disease with limited treatment options.
  • Drug resistance and lack of vaccines necessitate understanding the immune system's role in malaria pathogenesis.
  • The immune response in malaria is critical yet not fully understood.

Purpose of the Study:

  • To discuss a publication detailing how the immune system may exacerbate malaria.
  • To explore the link between mast cells, dendritic cells, and T cell activation in malaria.

Main Methods:

  • Analysis of plasma Flt3 ligand levels in Kenyan children with varying malaria severity.
  • Correlation of disease severity with frequencies of circulating BDCA3(+) dendritic cells.
  • Discussion of a publication on immune mechanisms promoting malaria pathogenesis.

Main Results:

  • Increased plasma Flt3 ligand levels were observed in children with mild and severe malaria.
  • Higher frequencies of circulating BDCA3(+) dendritic cells correlated positively with malaria severity.
  • BDCA3(+) dendritic cells, similar to rodent CD8(+) T cells, migrate to parasite-rich tissues and cause damage via cytolysis.

Conclusions:

  • Malaria parasites may induce pathogenesis by activating mast cells, expanding specific dendritic cells, and activating pathogenic CD8(+) T cells.
  • Mast cells might possess additional regulatory functions in malaria.
  • Selective inhibition of mast cell activation presents a potential adjuvant therapy for malaria.